galantamine has been researched along with Substance Withdrawal Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Aquino, JP; Poling, J; Sofuoglu, M; Sugarman, DE | 1 |
| Gould, TJ; Wilkinson, DS | 1 |
| Lai, M; Liu, H; Liu, Y; Ma, B; Sun, A; Zhang, F; Zhou, W; Zhou, X; Zhu, H | 1 |
| Herman, AI; Li, Y; Sofuoglu, M; Waters, AJ | 1 |
| Ducardus, R; Dworacek, B; Dzoljic, MR; Rupreht, J; Schmitz, PI | 1 |
2 trial(s) available for galantamine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Feasibility and effects of galantamine on cognition in humans with cannabis use disorder.
Topics: Adolescent; Adult; Affect; Attention; Cholinesterase Inhibitors; Cognition; Craving; Double-Blind Method; Feasibility Studies; Female; Galantamine; Humans; Male; Marijuana Abuse; Middle Aged; Pilot Projects; Reaction Time; Self Report; Substance Withdrawal Syndrome; Young Adult | 2019 |
Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.
Topics: Behavior, Addictive; Blood Pressure; Cholinesterase Inhibitors; Cognition; Connecticut; Cross-Over Studies; Double-Blind Method; Female; Galantamine; Heart Rate; Humans; Infusions, Intravenous; Logistic Models; Male; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pilot Projects; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Task Performance and Analysis; Time Factors; Tobacco Use Disorder | 2012 |
3 other study(ies) available for galantamine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.
Topics: Animals; Cholinesterase Inhibitors; Conditioning, Classical; Dose-Response Relationship, Drug; Drug Administration Schedule; Fear; Galantamine; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome | 2011 |
Galantamine attenuates the heroin seeking behaviors induced by cues after prolonged withdrawal in rats.
Topics: Animals; Behavior, Animal; Cholinergic Antagonists; Cholinesterase Inhibitors; Cues; Drug-Seeking Behavior; Extinction, Psychological; Galantamine; Heroin; Mecamylamine; Motor Activity; Narcotics; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Scopolamine; Self Administration; Substance Withdrawal Syndrome; Ventral Tegmental Area | 2012 |
The involvement of the central cholinergic and endorphinergic systems in the nitrous oxide withdrawal syndrome in mice.
Topics: Animals; Brain; Endorphins; Galantamine; Humans; Male; Mice; Naloxone; Nitrous Oxide; Parasympathetic Nervous System; Physostigmine; Seizures; Substance Withdrawal Syndrome | 1983 |